Clinical trials have traditionally relied on frequentist statistics, but Bayesian methods are gaining momentum in modern trial design. With new FDA guidance released in 2026, Bayesian approaches are becoming more prominent in evaluating drugs and medical devices. This episode explains the differences between frequentist and Bayesian statistics, how Bayesian adaptive trials work, and why this shift matters for biostatistics and clinical research.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 [email protected]

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting